Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arysta lifescience australia pty ltd - etridiazole - wettable powder - etridiazole thiazole active 350.0 g/kg - fungicide - bed - plant - general | herbaceous ornamental plant | ornamental seedling | plant root | pot | potting mix, compost, manure | tu - pythium spp. | root rot | root rot - phytophthora spp. | stem rot | wilt rootrot or damping off | damping-off | grease spot | pythium blight | pythium root rot | pythium soil fungus | seedling root rot | soil fungi

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arysta lifescience australia pty ltd - daminozide - water soluble granules - daminozide hydrazide active 850.0 g/kg - plant regulator - aster | azalea | chrysanthemum or tanacetum | cosmos | gardenia | marigold | petunia | poinsettia | salvia species | zahnia | co - control of height | initiating flowering | controls height | promotes flowering

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arysta lifescience australia pty ltd - carboxin; cypermethrin 45:55; ethylene glycol - suspension concentrates for seed treatment (fs) - carboxin carbamate-phenylcarbamate active 400.0 g/l; cypermethrin 45:55 pyrethroid active 3.2 g/l; ethylene glycol solvent other 96.9 g/l - mixed function seed treat - barley | oats | stored barley | stored oats | stored triticale | stored wheat grain | triticale | wheat - bunt | flag smut on cereal | granary weevil | indian meal moth | lesser grain borer | loose smut - ustilago tritici | rice weevil | rust-red flour beetle | sawtoothed grain beetle | smut - ustilago segetum var hordei | tropical warehouse moth | covered smut | grain borer | seedborne flag smut | soilborne flag smut | trilletia tritici

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - diluent, not applicable - excipient ingredients: - prolastin-c is an alpha-1-proteinase inhibitor (human, alpha1-pi) indicated to increase serum alpha1-pi levels in adults with congenital deficiency of alpha-1 antitrypsin and with clinically significant emphysema (fev1 less than 80%). the data for clinical efficacy of prolastin-c is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials. clinical trials have only included patients who were not smoking.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 500 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 2000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 250 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 1000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in adults with haemophilia b,2) treatment and prevention of bleeding episodes in adults with haemophilia b (congenital factor ix deficiency),3) peri-operative management in adults with haemophilia b 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - nonacog gamma, quantity: 3000 iu - injection, powder for - excipient ingredients: histidine; sodium chloride; calcium chloride dihydrate; mannitol; sucrose; polysorbate 80 - 1) routine prophylaxis of bleeding episodes in patients with haemophilia b 2) treatment and prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) 3) peri-operative management in patients with haemophilia b